Case Studies, Pharmaceutical

Case Study – Unidose Nasal Spray Pump for Opioid Overdose

Although naloxone has long been available in injection format as a treatment for opioid overdose, administration relies on the presence of a suitably trained responder. This case study describes a collaborative drug repurposing project with Aptar Pharma to develop an easy-to-administer naloxone nasal spray. The resulting product has been successfully commercialized to broaden access to a life-saving therapeutic. Utilizing Aptar Pharma’s Unidose Liquid (UDS) device it is primeless, reliable, and intuitive. Collaboration accelerated time to market for the nasal spray via the FDA’s 505(b)(2) Abbreviated Approval Pathway (U.S.) creating valuable intellectual property. The global market for the product is in excess of $350 million (2021).

Download Case Study - Unidose Nasal Spray pump for opioid overdose
8 Sep 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More About nasal drug delivery expertise

This Might Also Be of Interest

5 Jan 2023

Case Study – Unidose Nasal Spray Pump for Epilepsy

Case Studies, Pharmaceutical, Product Solutions, Device Innovations, Market Insights

Read More
14 Dec 2022

Building Digital Solutions To Meet The Unique Therapeutic Needs of Patients

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions

Read More
30 Nov 2022

Drug Repositioning – Benefits and Challenges for Lifecycle Management

Webinars, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
24 Nov 2022

Step to Success in Nose-to-Brain Drug Delivery

Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
1 2 3 18

Request Access


Requesting access to Case Study – Unidose Nasal Spray Pump for Opioid Overdose.

  • This field is for validation purposes and should be left unchanged.
Back To Top